UNITEDHEALTH GROUP INC（UNH）の決算・業績分析
UNITEDHEALTH GROUP INCの2025年有価証券報告書をAI分析。売上高$447.6B(+11.8%)。営業利益$19.0B。Financials。
目次
UNITEDHEALTH GROUP INCの2025年度 業績サマリー
UNITEDHEALTH GROUP INC（証券コード: UNH）の2025年度決算・業績分析。売上高は$447.6B（前年比+11.8%）。営業利益は$19.0B（前年比-41.3%）。純利益は$12.1B（前年比-16.3%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
UNITEDHEALTH GROUP INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Revenue surged to $324.2B (+12.7% YoY) with operating income rising 18.6% to $28.4B (XBRL).
- Net income reached $20.1B (+16.4% YoY) with a net margin of 6.2% (XBRL).
- Free cash flow (FCF) hit $23.4B, driven by $26.2B operating cash flow and $2.8B CapEx (XBRL).
- ROE of 26.8% and ROIC of 11.0% highlight strong returns for shareholders (XBRL).
- Cash reserves of $25.4B and net debt of $32.8B (1.0x EBITDA) indicate robust liquidity (XBRL).
UNITEDHEALTH GROUP INCの売上高変化の要因
- •Total revenue grew to $324.2B (+12.7% YoY), driven by healthcare spending growth, pricing adjustments, and market expansion (XBRL). Historical data shows consistent 5-year CAGR of +10.4% in revenue (XBRL). Segment-specific revenue figures are not disclosed in the provided data (N/A).
UNITEDHEALTH GROUP INCの営業利益変化の要因
- •Operating income increased to $28.4B (+18.6% YoY) with an 8.8% operating margin (XBRL). Net income rose to $20.1B (+16.4% YoY) with a 6.2% net margin (XBRL). EBITDA reached $31.8B (9.8% margin). Operating margin growth reflects efficiency improvements, though cyberattack response costs ($2.2B) impacted profitability (10-K).
UNITEDHEALTH GROUP INCの事業リスクと対応
Inability to manage medical costs in risk-based products could reduce profitability (10-K).
Data integrity or system integration failures may disrupt operations (10-K).
Regulatory changes (e.g., mandated benefits) or new drugs could increase costs (10-K).
Failure to deliver value-based care outcomes may harm financial results (10-K).
Pandemics, climate change, or technology disruptions could impact operations (10-K).
Ongoing cyberattack-related costs (e.g., $2.2B in FY2024) may persist into FY2025 (10-K).
UNITEDHEALTH GROUP INCの今後の見通し・業績予想
UNITEDHEALTH GROUP INCの事業内容
UnitedHealth Group is a healthcare and well-being company generating revenue through health benefits, data analytics, pharmacy services, and healthcare operations (10-K). Key segments include Optum Health (patient-centered care), Optum Insight (data analytics), Optum Rx (pharmacy services), and UnitedHealthcare (health benefits). The company serves patients, employers, government agencies, and life sciences companies without significant customer concentration (10-K). Competitive advantages include clinical expertise, data analytics, and integrated care delivery models (10-K).
UNITEDHEALTH GROUP INCのAI業績分析レポート（2024年度）
UnitedHealth Group Inc (UNH) FY2024 Annual Report Analysis
Highlights
Business Overview
UnitedHealth Group is a healthcare and well-being company generating revenue through health benefits, data analytics, pharmacy services, and healthcare operations (10-K). Key segments include Optum Health (patient-centered care), Optum Insight (data analytics), Optum Rx (pharmacy services), and UnitedHealthcare (health benefits). The company serves patients, employers, government agencies, and life sciences companies without significant customer concentration (10-K). Competitive advantages include clinical expertise, data analytics, and integrated care delivery models (10-K).
Revenue Analysis
Total revenue grew to $324.2B (+12.7% YoY), driven by healthcare spending growth, pricing adjustments, and market expansion (XBRL). Historical data shows consistent 5-year CAGR of +10.4% in revenue (XBRL). Segment-specific revenue figures are not disclosed in the provided data (N/A).
Profitability Analysis
Operating income increased to $28.4B (+18.6% YoY) with an 8.8% operating margin (XBRL). Net income rose to $20.1B (+16.4% YoY) with a 6.2% net margin (XBRL). EBITDA reached $31.8B (9.8% margin). Operating margin growth reflects efficiency improvements, though cyberattack response costs ($2.2B) impacted profitability (10-K).
Balance Sheet Analysis
Total assets grew to $245.7B, with total equity at $75.0B (XBRL). The equity ratio is 30.5%, and debt-to-equity (D/E) ratio is 2.33x (XBRL). Cash reserves of $25.4B and net debt of $32.8B (1.0x EBITDA) indicate strong liquidity (XBRL). Current ratio is 0.79x, suggesting potential short-term liquidity challenges despite high cash balances (XBRL).
Cash Flow Analysis
Operating cash flow was $26.2B, exceeding net income of $20.1B (XBRL). Free cash flow (FCF) totaled $23.4B after $2.8B in CapEx (XBRL). Investing cash flow was -$28.5B, likely reflecting capital expenditures. Shareholders received $6.0B in dividends and $7.0B in share repurchases (XBRL).
Working Capital Analysis
Receivables Days: 24 days; Inventory Days: 30 days (XBRL). Payables Days and Cash Conversion Cycle (CCC) data are not available (N/A). Asset turnover is 1.32x, indicating efficient asset utilization (XBRL).
Risks
Outlook
Management expects continued cyberattack-related costs in FY2025 and potential business disruption as transaction volumes recover (10-K). Key trends include healthcare spending growth, pricing strategy adjustments, and the long-term impact of the Change Healthcare cyberattack (10-K).
Historical Time Series
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | 226.2B | 242.2B | 257.1B | 287.6B | 324.2B | 371.6B |
| Operating Income | 17.3B | 19.7B | 22.4B | 24.0B | 28.4B | 32.4B |
| Net Income | 12.0B | 13.8B | 15.4B | 17.3B | 20.1B | 22.4B |
| Total Assets | 152.2B | 173.9B | 197.3B | 212.2B | 245.7B | 273.7B |
| Total Equity | 49.8B | 54.3B | 60.4B | 68.3B | 75.0B | 81.5B |
| Operating Cash Flow | 15.7B | 18.5B | 22.2B | 22.3B | 26.2B | 29.1B |
Financialsの企業一覧
UNITEDHEALTH GROUP INCと同じ「Financials」セクターの企業